Srebotnik Kirbiš I, Roque RR, Strojan Fležar M.

Integrated On-Slide Positive Controls for Immunocytochemistry on Cytology Slides.

Acta Cytol. 2024 Jul 19:1-7.

Srebotnik Kirbis I, Kholova I, Huhtala H, Bongiovanni M, Strojan Flezar M, Hodgson C, Cochand-Priollet B.

Cell block practices in European cytopathology laboratories.

Cancer Cytopathol. 2024 Apr;132(4):250-259.

Jevšinek Skok D, Bolha L, Hauptman N.

Preservation of 5-hydroxymethylcytosine levels in LRIG1 across genomic DNA and cell-free DNA in glioma patients.

Genes 2024; 5:535.

Draškovič T, Hauptman N.

Discovery of novel DNA methylation biomarker panels for the diagnosis and differentiation between common adenocarcinomas and their liver metastases.

Scientific Reports 2024; 14: 3095.

Hauptman N, Pižem J, Jevšinek Skok D.

AmiCa: atlas of miRNA-gene correlations in cancer.

Computational and Structural Biotechnology Journal 2024; 23: 2277-2288.

Šekoranja D, Zupan A, Matjašič A, Boštjančič E, Calonje E, Pižem J

Role of targeted sequencing in routine diagnostics of spitz melanocytic neoplasms: an analysis of 70 cases.

Journal of cutaneous pathology. 2024: 1-13.

Pižem J, Boštjančič E, Zupan A, Salapura V, Mavčič B, Blatnik A, Blatnik O, Unk M, Kern I, Švarc M, Matjašič A, et al.

Multifocal vascular neoplasm with an EWSR1::NFATC2 gene fusion and progression to epithelioid angiosarcoma : a case report.

Virchows Archiv 2024: 1-7. Dec;485(6):1175-1181.

Čugura T, Boštjančič E, Uhan S, Hauptman N, Jeruc J

Epithelial-mesenchymal transition associated markers in sarcomatoid transformation of clear cell renal cell carcinoma.

Experimental and molecular pathology 2024; 138: 1-12.

Draškovič T, Ranković, B, Zidar N, Hauptman N (avtor, korespondenčni avtor).

Upregulation of ABLIM1 differentiates intrahepatic cholangiocarcinoma from hepatocellular carcinoma and both colorectal and pancreatic adenocarcinoma liver metastases.

Genes. 2024, vol. 15, iss. 12, [article no.] 1545, str. 1-15.

Draškovič T, Ranković B, Zidar N, Hauptman N (avtor, korespondenčni avtor

DNA methylation biomarker panels for differentiating various liver adenocarcinomas, including hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases and pancreatic adenocarcinoma liver metastases.

Clinical epigenetics. Nov. 2024, vol. 16, no. 1, [article no.] 153, str. 1-15, ilustr. ISSN 1868-7083.